Capienda provides missing results for better small molecule designs: higher quality drugs enter clinical trials, saving up to $1 Billion +2 years per new drug.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free